Literature DB >> 15265873

Chain termination and inhibition of Saccharomyces cerevisiae poly(A) polymerase by C-8-modified ATP analogs.

Lisa S Chen1, Terry L Sheppard.   

Abstract

The nucleotide substrate specificity of yeast poly(A) polymerase (yPAP) toward various C-2- and C-8-modified ATP analogs was examined. 32P-Radiolabeled RNA oligonucleotide primers were incubated with yPAP in the absence of ATP to assay polyadenylation using unnatural ATP substrates. The C-2-modified ATP analogs 2-amino-ATP and 2-chloro (Cl)-ATP were excellent substrates for yPAP. 8-Amino-ATP, 8-azido-ATP, and 8-aza-ATP all produced chain termination of polyadenylation, and no primer extension was observed with the C-8-halogenated derivatives 8-Br-ATP and 8-Cl-ATP. The effects of modified ATP analogs on ATP-dependent poly(A) tail synthesis by yPAP were also examined. Whereas C-2 substitution (2-amino-ATP and 2-Cl-ATP) had little effect on poly(A) tail length, C-8 substitution produced moderate (8-amino-ATP, 8-azido-ATP, and 8-aza-ATP) to substantial (8-Br-ATP and 8-Cl-ATP) reduction in poly(A) tail length. To model the biochemical consequences of 8-Cl-Ado incorporation into RNA primers, a synthetic RNA primer containing a 3'-terminal 8-Cl-AMP residue was prepared. Polyadenylation of this modified RNA primer by yPAP in the presence of ATP was blocked completely. To probe potential mechanisms of inhibition, two-dimensional NMR spectroscopy experiments were used to examine the conformation of two C-8-modified AMP nucleotides, 8-Cl-AMP and 8-amino-AMP. C-8 substitution in adenosine analogs shifted the ribose sugar pucker equilibrium to favor the DNA-like C-2'-endo form over the C-3'-endo (RNA-like) conformation, which suggests a potential mechanism for polyadenylation inhibition and chain termination. Base-modified ATP analogs may exert their biological effects through polyadenylation inhibition and thus may provide useful tools for investigating polyadenylation biochemistry within cells. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265873     DOI: 10.1074/jbc.M401752200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Fluorescent 5-Pyrimidine and 8-Purine Nucleosides Modified with an N-Unsubstituted 1,2,3-Triazol-4-yl Moiety.

Authors:  Zhiwei Wen; Paloma R Tuttle; A Hasan Howlader; Anna Vasilyeva; Laura Gonzalez; Antonija Tangar; Ruipeng Lei; Eduardo E Laverde; Yuan Liu; Jaroslava Miksovska; Stanislaw F Wnuk
Journal:  J Org Chem       Date:  2019-03-06       Impact factor: 4.354

2.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

3.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

4.  ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.

Authors:  Fabiola Cervantes-Gomez; Ramadevi Nimmanapalli; Varsha Gandhi
Journal:  J Pharmacol Exp Ther       Date:  2011-08-05       Impact factor: 4.030

5.  8-Amino-adenosine inhibits multiple mechanisms of transcription.

Authors:  Jennifer Ann Frey; Varsha Gandhi
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

6.  Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis.

Authors:  Jennifer B Dennison; Kumudha Balakrishnan; Varsha Gandhi
Journal:  Br J Haematol       Date:  2009-08-25       Impact factor: 6.998

7.  Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivatives.

Authors:  Raghu Ningegowda; Amit Grover; S Ranjith; Kanchugarakoppal S Rangappa; B S Priya; S Nanjunda Swamy
Journal:  Invest New Drugs       Date:  2009-09-16       Impact factor: 3.850

8.  A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.

Authors:  Christine M Stellrecht; Mary Ayres; Rishi Arya; Varsha Gandhi
Journal:  Breast Cancer Res Treat       Date:  2009-07-30       Impact factor: 4.872

9.  Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues.

Authors:  Lisa S Chen; Lei Du-Cuny; Vasupradha Vethantham; David H Hawke; James L Manley; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-10-06       Impact factor: 5.858

10.  Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.

Authors:  Lisa S Chen; William Plunkett; Varsha Gandhi
Journal:  Leuk Res       Date:  2008-04-22       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.